Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
LEI: 213800NNT42FFIZB1T09 27 March 2026 Transactions in Own Shares Foresight Group Holdings Limited ("Foresight", the "Group"), a leading investment manager in real assets and providing capital for...
-
27 MARCH 2026 NORTHERN 2 VCT PLC TRANSACTION IN OWN SHARES Northern 2 VCT PLC (“the Company”) announces that on 26 March 2026 it purchased for cancellation under an existing authority granted by...
-
27 MARCH 2026 NORTHERN VENTURE TRUST PLC TRANSACTION IN OWN SHARES Northern Venture Trust PLC (“the Company”) announces that on 26 March 2026 it purchased for cancellation under an existing...
-
THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO AUSTRALIA, CANADA, ITALY, DENMARK, JAPAN, THE UNITED STATES, OR TO ANY NATIONAL OF SUCH JURISDICTIONS NB...
-
26 MARCH 2026 NORTHERN 3 VCT PLC TRANSACTION IN OWN SHARES Northern 3 VCT PLC (“the Company”) announces that on 26 March 2026 it purchased for cancellation under an existing authority granted by...
-
ALBION ENTERPRISE VCT PLC LEI Code 213800OVSRDHRJBMO720 TRANSACTION IN OWN SHARES AND TOTAL VOTING RIGHTS AND CAPITAL Albion Enterprise VCT PLC (the “Company”) announces that it purchased 2,792,108...
-
-
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR...
-
WALTHAM, Mass., March 27, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas,” “Zenas BioPharma” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to...
-
HOUSTON, March 26, 2026 (GLOBE NEWSWIRE) -- Itafos Inc. (TSX-V: IFOS) (the “Company”) announced today that the Company has granted, in the aggregate, 477,535 restricted share units (“RSUs”) and...